Light imaging contrast agents
AssigneeNycomed Imaging AS, a Oslo, Norway Corporation
InventorsJo Klaveness, Bjorn Fuglass, Pal Rongved, Edvin Johannesen, Paul Mark Henrichs, Wolfgang Hans Heinrich Gunther, Edward Richard Bacon, John Luke Toner, Gregory Lynn McIntire, Vinay C. Desai
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
Claims34
A method of generating an image of the human or non-human animal body by light imaging, characterized in that a physiologically tolerable particulate contrast agent is administered to said body and an image of at least part of said body is generated.
A method of manufacturing a particulate contrast agent for in vivo diagnostic light imaging comprising combining a physiologically tolerable particulate material and a medium.
A method of generating an image of the human or non-human animal body by light imaging comprising manufacturing a particulate contrast agent for in vivo diagnostic light imaging including a physiologically tolerable particulate material, administering the contrast agent to said body, and generating an image of at least part of said body.
A diagnostic imaging composition comprising a physiologically tolerable particulate agent comprising solid particles coated with a photolabel having a molar absorptivity of at least 105 cm−1M−1 and an absorption maximum in the range 300 to 1300 nm.
A method of diagnosing diseased states comprising generating an image of the human or non-human animal body by light imaging by in vivo spectroscopy of a physiologically tolerable particulate contrast agent.
Dependencies are inferred from the claim text.